Orchestra BioMed
OBIO
OBIO
58 hedge funds and large institutions have $47.6M invested in Orchestra BioMed in 2025 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 14 increasing their positions, 16 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
13% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 16
41% less capital invested
Capital invested by funds: $81.3M → $47.6M (-$33.7M)
Holders
58
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.1M | |
| 2 | +$454K | |
| 3 | +$268K | |
| 4 |
RI
RTW Investments
New York
|
+$268K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$229K |
Top Sellers
| 1 | -$3.39M | |
| 2 | -$921K | |
| 3 | -$786K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$403K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$371K |
